The global Aurora Kinase A market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Aurora Kinase A production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Aurora Kinase A by regions (countries) and by Application.
The global Aurora Kinase A market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Aurora Kinase A market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Aurora Kinase A markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Aurora Kinase A market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Aurora Kinase A market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Aurora Kinase A market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Aurora Kinase A market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Aurora Kinase A market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Aurora Kinase A market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Aurora Kinase A market by each application segment for the same period.
This report includes the following manufacturers:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
Market Segment by Type
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others
Market Segment by Application
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others
Research Methodology
To compile the detailed study of the global Aurora Kinase A market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Aurora Kinase A market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Aurora Kinase A market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Aurora Kinase A production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Aurora Kinase A by regions (countries) and by Application.
The global Aurora Kinase A market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Aurora Kinase A market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Aurora Kinase A markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Aurora Kinase A market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Aurora Kinase A market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Aurora Kinase A market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Aurora Kinase A market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Aurora Kinase A market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Aurora Kinase A market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Aurora Kinase A market by each application segment for the same period.
This report includes the following manufacturers:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
Market Segment by Type
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others
Market Segment by Application
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others
Research Methodology
To compile the detailed study of the global Aurora Kinase A market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Aurora Kinase A market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Aurora Kinase A market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Aurora Kinase A Market Size Growth Rate by Type
1.2.2 AMG-900
1.2.3 Danusertib
1.2.4 ENMD-2076
1.2.5 Ilorasertib
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Aurora Kinase A Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Ovarian Cancer
1.3.3 Anaplastic Large Cell Lymphoma
1.3.4 Brain Tumor
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Aurora Kinase A Market Size (2016-2027)
2.1.1 Global Aurora Kinase A Revenue (2016-2027)
2.1.2 Global Aurora Kinase A Sales (2016-2027)
2.2 Global Aurora Kinase A Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Aurora Kinase A Sales by Regions (2016-2021)
2.2.2 Global Aurora Kinase A Revenue by Regions (2016-2021)
2.3 Global Aurora Kinase A Market Size Forecast by Region
2.3.1 Global Aurora Kinase A Sales Forecast by Region (2022-2027)
2.3.2 Global Aurora Kinase A Revenue Forecast by Region (2022-2027)
2.4 Global Top Aurora Kinase A Regions (Countries) Ranking by Market Size
2.5 Aurora Kinase A Industry Trends
2.5.1 Aurora Kinase A Market Trends
2.5.2 Aurora Kinase A Market Drivers
2.5.3 Aurora Kinase A Market Challenges
2.5.4 Aurora Kinase A Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Aurora Kinase A Manufacturers by Sales (2016-2021)
3.1.1 Global Aurora Kinase A Sales by Manufacturers (2016-2021)
3.1.2 Global Aurora Kinase A Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Aurora Kinase A Sales in 2020
3.2 Global Top Manufacturers Aurora Kinase A by Revenue
3.2.1 Global Aurora Kinase A Revenue by Manufacturers (2016-2021)
3.2.2 Top Aurora Kinase A Manufacturers Covered: Ranking by Revenue
3.2.3 Global Aurora Kinase A Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Aurora Kinase A Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase A as of 2020)
3.4 Global Aurora Kinase A Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Aurora Kinase A Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Aurora Kinase A Market
3.7 Key Manufacturers Aurora Kinase A Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Aurora Kinase A Market Size by Type
4.1 Global Aurora Kinase A Historic Market Review by Type (2016-2021)
4.1.1 Global Aurora Kinase A Sales Market Share by Type (2016-2021)
4.1.2 Global Aurora Kinase A Revenue Market Share by Type (2016-2021)
4.1.3 Aurora Kinase A Price by Type (2016-2021)
4.2 Global Aurora Kinase A Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Aurora Kinase A Sales Forecast by Type (2022-2027)
4.2.2 Global Aurora Kinase A Revenue Forecast by Type (2022-2027)
4.2.3 Aurora Kinase A Price Forecast by Type (2022-2027)
5 Global Aurora Kinase A Market Size by Application
5.1 Global Aurora Kinase A Historic Market Review by Application (2016-2021)
5.1.1 Global Aurora Kinase A Sales Market Share by Application (2016-2021)
5.1.2 Global Aurora Kinase A Revenue Market Share by Application (2016-2021)
5.1.3 Aurora Kinase A Price by Application (2016-2021)
5.2 Global Aurora Kinase A Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Aurora Kinase A Sales Forecast by Application (2022-2027)
5.2.2 Global Aurora Kinase A Revenue Forecast by Application (2022-2027)
5.2.3 Aurora Kinase A Price Forecast by Application (2022-2027)
6 North America
6.1 North America Aurora Kinase A Sales Breakdown by Company
6.1.1 North America Aurora Kinase A Sales by Company (2016-2027)
6.1.2 North America Aurora Kinase A Revenue by Company (2016-2027)
6.2 North America Aurora Kinase A Market Size by Type (2016-2027)
6.2.1 North America Aurora Kinase A Sales by Type (2016-2027)
6.2.2 North America Aurora Kinase A Revenue by Type (2016-2027)
6.3 North America Aurora Kinase A Market Size by Application (2016-2027)
6.3.1 North America Aurora Kinase A Sales by Application (2016-2027)
6.3.2 North America Aurora Kinase A Revenue by Application (2016-2027)
6.4 North America Aurora Kinase A Market Size by Country
6.4.1 North America Aurora Kinase A Sales by Country (2016-2027)
6.4.2 North America Aurora Kinase A Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Aurora Kinase A Sales Breakdown by Company
7.1.1 Europe Aurora Kinase A Sales by Company (2016-2027)
7.1.2 Europe Aurora Kinase A Revenue by Company (2016-2027)
7.2 Europe Aurora Kinase A Market Size by Type (2016-2027)
7.2.1 Europe Aurora Kinase A Sales by Type (2016-2027)
7.2.2 Europe Aurora Kinase A Revenue by Type (2016-2027)
7.3 Europe Aurora Kinase A Market Size by Application (2016-2027)
7.3.1 Europe Aurora Kinase A Sales by Application (2016-2027)
7.3.2 Europe Aurora Kinase A Revenue by Application (2016-2027)
7.4 Europe Aurora Kinase A Market Size by Country
7.4.1 Europe Aurora Kinase A Sales by Country (2016-2027)
7.4.2 Europe Aurora Kinase A Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Aurora Kinase A Sales Breakdown by Company
8.1.1 Asia Pacific Aurora Kinase A Sales by Company (2016-2027)
8.1.2 Asia Pacific Aurora Kinase A Revenue by Company (2016-2027)
8.2 Asia Pacific Aurora Kinase A Market Size by Type (2016-2027)
8.2.1 Asia Pacific Aurora Kinase A Sales by Type (2016-2027)
8.2.2 Asia Pacific Aurora Kinase A Revenue by Type (2016-2027)
8.3 Asia Pacific Aurora Kinase A Market Size by Application (2016-2027)
8.3.1 Asia Pacific Aurora Kinase A Sales by Application (2016-2027)
8.3.2 Asia Pacific Aurora Kinase A Revenue by Application (2016-2027)
8.4 Asia Pacific Aurora Kinase A Market Size by Regions
8.4.1 Asia Pacific Aurora Kinase A Sales by Regions
8.4.2 Asia Pacific Aurora Kinase A Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Aurora Kinase A Sales Breakdown by Company
9.1.1 Latin America Aurora Kinase A Sales by Company (2016-2027)
9.1.2 Latin America Aurora Kinase A Revenue by Company (2016-2027)
9.2 Latin America Aurora Kinase A Market Size by Type (2016-2027)
9.2.1 Latin America Aurora Kinase A Sales by Type (2016-2027)
9.2.2 Latin America Aurora Kinase A Revenue by Type (2016-2027)
9.3 Latin America Aurora Kinase A Market Size by Application (2016-2027)
9.3.1 Latin America Aurora Kinase A Sales by Application (2016-2027)
9.3.2 Latin America Aurora Kinase A Revenue by Application (2016-2027)
9.4 Latin America Aurora Kinase A Market Size by Country
9.4.1 Latin America Aurora Kinase A Sales by Country (2016-2027)
9.4.2 Latin America Aurora Kinase A Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Aurora Kinase A Sales Breakdown by Company
10.1.1 Middle East and Africa Aurora Kinase A Sales by Company (2016-2027)
10.1.2 Middle East and Africa Aurora Kinase A Revenue by Company (2016-2027)
10.2 Middle East and Africa Aurora Kinase A Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Aurora Kinase A Sales by Type (2016-2027)
10.2.2 Middle East and Africa Aurora Kinase A Revenue by Type (2016-2027)
10.3 Middle East and Africa Aurora Kinase A Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Aurora Kinase A Sales by Application (2016-2027)
10.3.2 Middle East and Africa Aurora Kinase A Revenue by Application (2016-2027)
10.4 Middle East and Africa Aurora Kinase A Market Size by Country
10.4.1 Middle East and Africa Aurora Kinase A Sales by Country (2016-2027)
10.4.2 Middle East and Africa Aurora Kinase A Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Overview
11.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 AbbVie Inc. Aurora Kinase A Products and Services
11.1.5 AbbVie Inc. Aurora Kinase A SWOT Analysis
11.1.6 AbbVie Inc. Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Overview
11.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Amgen Inc. Aurora Kinase A Products and Services
11.2.5 Amgen Inc. Aurora Kinase A SWOT Analysis
11.2.6 Amgen Inc. Recent Developments
11.3 Astex Pharmaceuticals, Inc.
11.3.1 Astex Pharmaceuticals, Inc. Corporation Information
11.3.2 Astex Pharmaceuticals, Inc. Overview
11.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Products and Services
11.3.5 Astex Pharmaceuticals, Inc. Aurora Kinase A SWOT Analysis
11.3.6 Astex Pharmaceuticals, Inc. Recent Developments
11.4 CASI Pharmaceuticals Inc.
11.4.1 CASI Pharmaceuticals Inc. Corporation Information
11.4.2 CASI Pharmaceuticals Inc. Overview
11.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Products and Services
11.4.5 CASI Pharmaceuticals Inc. Aurora Kinase A SWOT Analysis
11.4.6 CASI Pharmaceuticals Inc. Recent Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Corporation Information
11.5.2 Merck & Co., Inc. Overview
11.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Merck & Co., Inc. Aurora Kinase A Products and Services
11.5.5 Merck & Co., Inc. Aurora Kinase A SWOT Analysis
11.5.6 Merck & Co., Inc. Recent Developments
11.6 Millennium Pharmaceuticals, Inc.
11.6.1 Millennium Pharmaceuticals, Inc. Corporation Information
11.6.2 Millennium Pharmaceuticals, Inc. Overview
11.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Products and Services
11.6.5 Millennium Pharmaceuticals, Inc. Aurora Kinase A SWOT Analysis
11.6.6 Millennium Pharmaceuticals, Inc. Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Sanofi Aurora Kinase A Products and Services
11.7.5 Sanofi Aurora Kinase A SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Sareum Holdings Plc
11.8.1 Sareum Holdings Plc Corporation Information
11.8.2 Sareum Holdings Plc Overview
11.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Sareum Holdings Plc Aurora Kinase A Products and Services
11.8.5 Sareum Holdings Plc Aurora Kinase A SWOT Analysis
11.8.6 Sareum Holdings Plc Recent Developments
11.9 Sigma-Tau S.p.A.
11.9.1 Sigma-Tau S.p.A. Corporation Information
11.9.2 Sigma-Tau S.p.A. Overview
11.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Sigma-Tau S.p.A. Aurora Kinase A Products and Services
11.9.5 Sigma-Tau S.p.A. Aurora Kinase A SWOT Analysis
11.9.6 Sigma-Tau S.p.A. Recent Developments
11.10 Taiho Pharmaceutical Co., Ltd.
11.10.1 Taiho Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Taiho Pharmaceutical Co., Ltd. Overview
11.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Products and Services
11.10.5 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A SWOT Analysis
11.10.6 Taiho Pharmaceutical Co., Ltd. Recent Developments
11.11 Vertex Pharmaceuticals Incorporated
11.11.1 Vertex Pharmaceuticals Incorporated Corporation Information
11.11.2 Vertex Pharmaceuticals Incorporated Overview
11.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Products and Services
11.11.5 Vertex Pharmaceuticals Incorporated Recent Developments
11.12 Vichem Chemie Research Ltd.
11.12.1 Vichem Chemie Research Ltd. Corporation Information
11.12.2 Vichem Chemie Research Ltd. Overview
11.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Vichem Chemie Research Ltd. Aurora Kinase A Products and Services
11.12.5 Vichem Chemie Research Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Aurora Kinase A Value Chain Analysis
12.2 Aurora Kinase A Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aurora Kinase A Production Mode & Process
12.4 Aurora Kinase A Sales and Marketing
12.4.1 Aurora Kinase A Sales Channels
12.4.2 Aurora Kinase A Distributors
12.5 Aurora Kinase A Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Aurora Kinase A Market Size Growth Rate by Type
1.2.2 AMG-900
1.2.3 Danusertib
1.2.4 ENMD-2076
1.2.5 Ilorasertib
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Aurora Kinase A Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Ovarian Cancer
1.3.3 Anaplastic Large Cell Lymphoma
1.3.4 Brain Tumor
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Aurora Kinase A Market Size (2016-2027)
2.1.1 Global Aurora Kinase A Revenue (2016-2027)
2.1.2 Global Aurora Kinase A Sales (2016-2027)
2.2 Global Aurora Kinase A Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Aurora Kinase A Sales by Regions (2016-2021)
2.2.2 Global Aurora Kinase A Revenue by Regions (2016-2021)
2.3 Global Aurora Kinase A Market Size Forecast by Region
2.3.1 Global Aurora Kinase A Sales Forecast by Region (2022-2027)
2.3.2 Global Aurora Kinase A Revenue Forecast by Region (2022-2027)
2.4 Global Top Aurora Kinase A Regions (Countries) Ranking by Market Size
2.5 Aurora Kinase A Industry Trends
2.5.1 Aurora Kinase A Market Trends
2.5.2 Aurora Kinase A Market Drivers
2.5.3 Aurora Kinase A Market Challenges
2.5.4 Aurora Kinase A Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Aurora Kinase A Manufacturers by Sales (2016-2021)
3.1.1 Global Aurora Kinase A Sales by Manufacturers (2016-2021)
3.1.2 Global Aurora Kinase A Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Aurora Kinase A Sales in 2020
3.2 Global Top Manufacturers Aurora Kinase A by Revenue
3.2.1 Global Aurora Kinase A Revenue by Manufacturers (2016-2021)
3.2.2 Top Aurora Kinase A Manufacturers Covered: Ranking by Revenue
3.2.3 Global Aurora Kinase A Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Aurora Kinase A Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase A as of 2020)
3.4 Global Aurora Kinase A Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Aurora Kinase A Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Aurora Kinase A Market
3.7 Key Manufacturers Aurora Kinase A Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Aurora Kinase A Market Size by Type
4.1 Global Aurora Kinase A Historic Market Review by Type (2016-2021)
4.1.1 Global Aurora Kinase A Sales Market Share by Type (2016-2021)
4.1.2 Global Aurora Kinase A Revenue Market Share by Type (2016-2021)
4.1.3 Aurora Kinase A Price by Type (2016-2021)
4.2 Global Aurora Kinase A Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Aurora Kinase A Sales Forecast by Type (2022-2027)
4.2.2 Global Aurora Kinase A Revenue Forecast by Type (2022-2027)
4.2.3 Aurora Kinase A Price Forecast by Type (2022-2027)
5 Global Aurora Kinase A Market Size by Application
5.1 Global Aurora Kinase A Historic Market Review by Application (2016-2021)
5.1.1 Global Aurora Kinase A Sales Market Share by Application (2016-2021)
5.1.2 Global Aurora Kinase A Revenue Market Share by Application (2016-2021)
5.1.3 Aurora Kinase A Price by Application (2016-2021)
5.2 Global Aurora Kinase A Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Aurora Kinase A Sales Forecast by Application (2022-2027)
5.2.2 Global Aurora Kinase A Revenue Forecast by Application (2022-2027)
5.2.3 Aurora Kinase A Price Forecast by Application (2022-2027)
6 North America
6.1 North America Aurora Kinase A Sales Breakdown by Company
6.1.1 North America Aurora Kinase A Sales by Company (2016-2027)
6.1.2 North America Aurora Kinase A Revenue by Company (2016-2027)
6.2 North America Aurora Kinase A Market Size by Type (2016-2027)
6.2.1 North America Aurora Kinase A Sales by Type (2016-2027)
6.2.2 North America Aurora Kinase A Revenue by Type (2016-2027)
6.3 North America Aurora Kinase A Market Size by Application (2016-2027)
6.3.1 North America Aurora Kinase A Sales by Application (2016-2027)
6.3.2 North America Aurora Kinase A Revenue by Application (2016-2027)
6.4 North America Aurora Kinase A Market Size by Country
6.4.1 North America Aurora Kinase A Sales by Country (2016-2027)
6.4.2 North America Aurora Kinase A Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Aurora Kinase A Sales Breakdown by Company
7.1.1 Europe Aurora Kinase A Sales by Company (2016-2027)
7.1.2 Europe Aurora Kinase A Revenue by Company (2016-2027)
7.2 Europe Aurora Kinase A Market Size by Type (2016-2027)
7.2.1 Europe Aurora Kinase A Sales by Type (2016-2027)
7.2.2 Europe Aurora Kinase A Revenue by Type (2016-2027)
7.3 Europe Aurora Kinase A Market Size by Application (2016-2027)
7.3.1 Europe Aurora Kinase A Sales by Application (2016-2027)
7.3.2 Europe Aurora Kinase A Revenue by Application (2016-2027)
7.4 Europe Aurora Kinase A Market Size by Country
7.4.1 Europe Aurora Kinase A Sales by Country (2016-2027)
7.4.2 Europe Aurora Kinase A Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Aurora Kinase A Sales Breakdown by Company
8.1.1 Asia Pacific Aurora Kinase A Sales by Company (2016-2027)
8.1.2 Asia Pacific Aurora Kinase A Revenue by Company (2016-2027)
8.2 Asia Pacific Aurora Kinase A Market Size by Type (2016-2027)
8.2.1 Asia Pacific Aurora Kinase A Sales by Type (2016-2027)
8.2.2 Asia Pacific Aurora Kinase A Revenue by Type (2016-2027)
8.3 Asia Pacific Aurora Kinase A Market Size by Application (2016-2027)
8.3.1 Asia Pacific Aurora Kinase A Sales by Application (2016-2027)
8.3.2 Asia Pacific Aurora Kinase A Revenue by Application (2016-2027)
8.4 Asia Pacific Aurora Kinase A Market Size by Regions
8.4.1 Asia Pacific Aurora Kinase A Sales by Regions
8.4.2 Asia Pacific Aurora Kinase A Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Aurora Kinase A Sales Breakdown by Company
9.1.1 Latin America Aurora Kinase A Sales by Company (2016-2027)
9.1.2 Latin America Aurora Kinase A Revenue by Company (2016-2027)
9.2 Latin America Aurora Kinase A Market Size by Type (2016-2027)
9.2.1 Latin America Aurora Kinase A Sales by Type (2016-2027)
9.2.2 Latin America Aurora Kinase A Revenue by Type (2016-2027)
9.3 Latin America Aurora Kinase A Market Size by Application (2016-2027)
9.3.1 Latin America Aurora Kinase A Sales by Application (2016-2027)
9.3.2 Latin America Aurora Kinase A Revenue by Application (2016-2027)
9.4 Latin America Aurora Kinase A Market Size by Country
9.4.1 Latin America Aurora Kinase A Sales by Country (2016-2027)
9.4.2 Latin America Aurora Kinase A Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Aurora Kinase A Sales Breakdown by Company
10.1.1 Middle East and Africa Aurora Kinase A Sales by Company (2016-2027)
10.1.2 Middle East and Africa Aurora Kinase A Revenue by Company (2016-2027)
10.2 Middle East and Africa Aurora Kinase A Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Aurora Kinase A Sales by Type (2016-2027)
10.2.2 Middle East and Africa Aurora Kinase A Revenue by Type (2016-2027)
10.3 Middle East and Africa Aurora Kinase A Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Aurora Kinase A Sales by Application (2016-2027)
10.3.2 Middle East and Africa Aurora Kinase A Revenue by Application (2016-2027)
10.4 Middle East and Africa Aurora Kinase A Market Size by Country
10.4.1 Middle East and Africa Aurora Kinase A Sales by Country (2016-2027)
10.4.2 Middle East and Africa Aurora Kinase A Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Overview
11.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 AbbVie Inc. Aurora Kinase A Products and Services
11.1.5 AbbVie Inc. Aurora Kinase A SWOT Analysis
11.1.6 AbbVie Inc. Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Overview
11.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Amgen Inc. Aurora Kinase A Products and Services
11.2.5 Amgen Inc. Aurora Kinase A SWOT Analysis
11.2.6 Amgen Inc. Recent Developments
11.3 Astex Pharmaceuticals, Inc.
11.3.1 Astex Pharmaceuticals, Inc. Corporation Information
11.3.2 Astex Pharmaceuticals, Inc. Overview
11.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Products and Services
11.3.5 Astex Pharmaceuticals, Inc. Aurora Kinase A SWOT Analysis
11.3.6 Astex Pharmaceuticals, Inc. Recent Developments
11.4 CASI Pharmaceuticals Inc.
11.4.1 CASI Pharmaceuticals Inc. Corporation Information
11.4.2 CASI Pharmaceuticals Inc. Overview
11.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Products and Services
11.4.5 CASI Pharmaceuticals Inc. Aurora Kinase A SWOT Analysis
11.4.6 CASI Pharmaceuticals Inc. Recent Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Corporation Information
11.5.2 Merck & Co., Inc. Overview
11.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Merck & Co., Inc. Aurora Kinase A Products and Services
11.5.5 Merck & Co., Inc. Aurora Kinase A SWOT Analysis
11.5.6 Merck & Co., Inc. Recent Developments
11.6 Millennium Pharmaceuticals, Inc.
11.6.1 Millennium Pharmaceuticals, Inc. Corporation Information
11.6.2 Millennium Pharmaceuticals, Inc. Overview
11.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Products and Services
11.6.5 Millennium Pharmaceuticals, Inc. Aurora Kinase A SWOT Analysis
11.6.6 Millennium Pharmaceuticals, Inc. Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Sanofi Aurora Kinase A Products and Services
11.7.5 Sanofi Aurora Kinase A SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Sareum Holdings Plc
11.8.1 Sareum Holdings Plc Corporation Information
11.8.2 Sareum Holdings Plc Overview
11.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Sareum Holdings Plc Aurora Kinase A Products and Services
11.8.5 Sareum Holdings Plc Aurora Kinase A SWOT Analysis
11.8.6 Sareum Holdings Plc Recent Developments
11.9 Sigma-Tau S.p.A.
11.9.1 Sigma-Tau S.p.A. Corporation Information
11.9.2 Sigma-Tau S.p.A. Overview
11.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Sigma-Tau S.p.A. Aurora Kinase A Products and Services
11.9.5 Sigma-Tau S.p.A. Aurora Kinase A SWOT Analysis
11.9.6 Sigma-Tau S.p.A. Recent Developments
11.10 Taiho Pharmaceutical Co., Ltd.
11.10.1 Taiho Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Taiho Pharmaceutical Co., Ltd. Overview
11.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Products and Services
11.10.5 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A SWOT Analysis
11.10.6 Taiho Pharmaceutical Co., Ltd. Recent Developments
11.11 Vertex Pharmaceuticals Incorporated
11.11.1 Vertex Pharmaceuticals Incorporated Corporation Information
11.11.2 Vertex Pharmaceuticals Incorporated Overview
11.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Products and Services
11.11.5 Vertex Pharmaceuticals Incorporated Recent Developments
11.12 Vichem Chemie Research Ltd.
11.12.1 Vichem Chemie Research Ltd. Corporation Information
11.12.2 Vichem Chemie Research Ltd. Overview
11.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Vichem Chemie Research Ltd. Aurora Kinase A Products and Services
11.12.5 Vichem Chemie Research Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Aurora Kinase A Value Chain Analysis
12.2 Aurora Kinase A Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aurora Kinase A Production Mode & Process
12.4 Aurora Kinase A Sales and Marketing
12.4.1 Aurora Kinase A Sales Channels
12.4.2 Aurora Kinase A Distributors
12.5 Aurora Kinase A Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
